|
| 1-(Tert-butoxycarbonyl)-3-(methanesulfonyloxy)azetidine Basic information |
Product Name: | 1-(Tert-butoxycarbonyl)-3-(methanesulfonyloxy)azetidine | Synonyms: | 1-(Tert-butoxycarbonyl)-3-(methanesulfonyloxy)azetidine;3-((Methylsulfonyl)oxy)azetidine-1-carboxylic acid tert-butyl ester;3-[(Methanesulfonyl)oxy]azetidine-1-carboxylic acid tert-butyl ester;tert-Butyl 3-[(methylsulfonyl)oxy]azetane-1-carboxylate;1-(tert-butoxycarbonyl)azetidine-3-yl-methanesulfonate;N-Boc-3-methanesulfonyloxyazetidine;1-Boc-3-methanesulfonyloxy-azetidine;tert-Butyl 3-[(methylsulfonyl)oxy]-1-azetidinecarboxylate | CAS: | 141699-58-3 | MF: | C9H17NO5S | MW: | 251.3 | EINECS: | | Product Categories: | CMLLYL | Mol File: | 141699-58-3.mol |  |
| 1-(Tert-butoxycarbonyl)-3-(methanesulfonyloxy)azetidine Chemical Properties |
Melting point | 69 °C | Boiling point | 378.5±31.0 °C(Predicted) | density | 1.28±0.1 g/cm3(Predicted) | storage temp. | Keep in dark place,Sealed in dry,Room Temperature | pka | -4.18±0.40(Predicted) | form | powder to crystal | color | White to Light yellow | InChI | InChI=1S/C9H17NO5S/c1-9(2,3)14-8(11)10-5-7(6-10)15-16(4,12)13/h7H,5-6H2,1-4H3 | InChIKey | XXBDTKYKFFIAEY-UHFFFAOYSA-N | SMILES | N1(C(OC(C)(C)C)=O)CC(OS(C)(=O)=O)C1 |
Hazard Codes | T | Risk Statements | 25 | Safety Statements | 45 | RIDADR | UN 2811 6.1 / PGIII | HazardClass | IRRITANT | HS Code | 2933998090 |
| 1-(Tert-butoxycarbonyl)-3-(methanesulfonyloxy)azetidine Usage And Synthesis |
Synthesis | Preparation of Example 26-2: tert-butyl 3-((methylsulfonyl)oxy)azetidine-1-carboxylate
Under a nitrogen atmosphere, methanesulfonyl chloride (2.57 mL, 33.3 mmol) and triethylamine (11.6 mL, 83.1 mmol) were sequentially added to a solution of tetrahydrofuran (100 mL) containing N-Boc-3-hydroxyazetidine (4.8 g, 27.7 mmol). The reaction mixture was stirred at room temperature for 2 hours. Upon completion of the reaction, saturated aqueous sodium bicarbonate solution was added to the reaction solution and the mixture was diluted with ethyl acetate. The organic layer was separated, washed with saturated brine and subsequently dried over anhydrous sodium sulfate. The desiccant was removed by filtration and the filtrate was concentrated under vacuum. The residue was purified by silica gel column chromatography (eluent ratio: n-heptane/ethyl acetate = 9:1 to 1:1) to quantitatively obtain N-Boc-3-methylsulfonyloxyazetidine.
1H-NMR (CDCl3) δ (ppm): 1.45 (9H, s), 3.07 (3H, s), 4.03-4.18 (2H, m), 4.22-4.36 (2H, m), 5.12-5.27 (1H, m). | References | [1] Patent: US2014/235614, 2014, A1. Location in patent: Paragraph 0570; 0571; 0572 [2] Patent: EP1340757, 2003, A1 [3] Journal of Medicinal Chemistry, 2014, vol. 57, # 18, p. 7731 - 7757 [4] Patent: WO2018/102419, 2018, A1. Location in patent: Paragraph 0344; 0345; 0346; 0347 [5] Patent: US2012/10182, 2012, A1. Location in patent: Page/Page column 40 |
| 1-(Tert-butoxycarbonyl)-3-(methanesulfonyloxy)azetidine Preparation Products And Raw materials |
|